STAAR SURGICAL CO (STAA) Fundamental Analysis & Valuation

NASDAQ:STAA • US8523123052

Current stock price

18.58 USD
+0.73 (+4.09%)
At close:
18.96 USD
+0.38 (+2.05%)
Pre-Market:

This STAA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. STAA Profitability Analysis

1.1 Basic Checks

  • In the past year STAA has reported negative net income.
  • STAA had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: STAA reported negative net income in multiple years.
  • Of the past 5 years STAA 4 years had a positive operating cash flow.
STAA Yearly Net Income VS EBIT VS OCF VS FCFSTAA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -17.81%, STAA is in line with its industry, outperforming 52.72% of the companies in the same industry.
  • STAA's Return On Equity of -23.37% is in line compared to the rest of the industry. STAA outperforms 58.15% of its industry peers.
Industry RankSector Rank
ROA -17.81%
ROE -23.37%
ROIC N/A
ROA(3y)-5.8%
ROA(5y)-0.19%
ROE(3y)-7.64%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
STAA Yearly ROA, ROE, ROICSTAA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • The Gross Margin of STAA (76.19%) is better than 86.41% of its industry peers.
  • STAA's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for STAA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.01%
GM growth 5Y1.02%
STAA Yearly Profit, Operating, Gross MarginsSTAA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. STAA Health Analysis

2.1 Basic Checks

  • STAA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for STAA has been increased compared to 1 year ago.
  • STAA has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for STAA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
STAA Yearly Shares OutstandingSTAA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
STAA Yearly Total Debt VS Total AssetsSTAA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 5.54 indicates that STAA is not in any danger for bankruptcy at the moment.
  • STAA's Altman-Z score of 5.54 is amongst the best of the industry. STAA outperforms 80.98% of its industry peers.
  • There is no outstanding debt for STAA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.54
ROIC/WACCN/A
WACC10.11%
STAA Yearly LT Debt VS Equity VS FCFSTAA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 4.55 indicates that STAA has no problem at all paying its short term obligations.
  • STAA has a Current ratio of 4.55. This is in the better half of the industry: STAA outperforms 71.20% of its industry peers.
  • STAA has a Quick Ratio of 3.74. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 3.74, STAA is in the better half of the industry, outperforming 72.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 3.74
STAA Yearly Current Assets VS Current LiabilitesSTAA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. STAA Growth Analysis

3.1 Past

  • The earnings per share for STAA have decreased strongly by -421.21% in the last year.
  • Looking at the last year, STAA shows a very negative growth in Revenue. The Revenue has decreased by -23.72% in the last year.
  • STAA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.93% yearly.
EPS 1Y (TTM)-421.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26%
Revenue 1Y (TTM)-23.72%
Revenue growth 3Y-5.57%
Revenue growth 5Y7.93%
Sales Q2Q%18.08%

3.2 Future

  • STAA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.48% yearly.
  • The Revenue is expected to grow by 13.36% on average over the next years. This is quite good.
EPS Next Y113.33%
EPS Next 2Y61.1%
EPS Next 3Y36.59%
EPS Next 5Y34.48%
Revenue Next Year22%
Revenue Next 2Y14.87%
Revenue Next 3Y12.7%
Revenue Next 5Y13.36%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
STAA Yearly Revenue VS EstimatesSTAA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
STAA Yearly EPS VS EstimatesSTAA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

2

4. STAA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for STAA. In the last year negative earnings were reported.
  • STAA is valuated quite expensively with a Price/Forward Earnings ratio of 131.45.
  • 64.13% of the companies in the same industry are more expensive than STAA, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.80, STAA is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 131.45
STAA Price Earnings VS Forward Price EarningsSTAA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STAA Per share dataSTAA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • STAA's earnings are expected to grow with 36.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.1%
EPS Next 3Y36.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. STAA Dividend Analysis

5.1 Amount

  • STAA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STAA Fundamentals: All Metrics, Ratios and Statistics

STAAR SURGICAL CO

NASDAQ:STAA (3/18/2026, 8:00:00 PM)

Premarket: 18.96 +0.38 (+2.05%)

18.58

+0.73 (+4.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-03
Earnings (Next)05-05
Inst Owners108.81%
Inst Owner Change1.46%
Ins Owners0.31%
Ins Owner Change15.18%
Market Cap924.17M
Revenue(TTM)239.44M
Net Income(TTM)-80.45M
Analysts52.5
Price Target23.15 (24.6%)
Short Float %12.59%
Short Ratio4.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-362.76%
Min EPS beat(2)-734.84%
Max EPS beat(2)9.32%
EPS beat(4)3
Avg EPS beat(4)-165.83%
Min EPS beat(4)-734.84%
Max EPS beat(4)49.58%
EPS beat(8)6
Avg EPS beat(8)-476.9%
EPS beat(12)8
Avg EPS beat(12)-310.53%
EPS beat(16)12
Avg EPS beat(16)-209.31%
Revenue beat(2)1
Avg Revenue beat(2)-11.28%
Min Revenue beat(2)-24.81%
Max Revenue beat(2)2.26%
Revenue beat(4)3
Avg Revenue beat(4)-2.67%
Min Revenue beat(4)-24.81%
Max Revenue beat(4)8.25%
Revenue beat(8)5
Avg Revenue beat(8)-5.77%
Revenue beat(12)6
Avg Revenue beat(12)-3.68%
Revenue beat(16)7
Avg Revenue beat(16)-2.83%
PT rev (1m)-2.85%
PT rev (3m)-7.84%
EPS NQ rev (1m)-9.21%
EPS NQ rev (3m)-9.21%
EPS NY rev (1m)156.61%
EPS NY rev (3m)264.96%
Revenue NQ rev (1m)-0.68%
Revenue NQ rev (3m)-0.68%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 131.45
P/S 3.86
P/FCF N/A
P/OCF N/A
P/B 2.69
P/tB 2.96
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)0.14
Fwd EY0.76%
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS4.81
BVpS6.92
TBVpS6.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.81%
ROE -23.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.19%
FCFM N/A
ROA(3y)-5.8%
ROA(5y)-0.19%
ROE(3y)-7.64%
ROE(5y)-0.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.01%
GM growth 5Y1.02%
F-Score3
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.68%
Cap/Sales 2.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 3.74
Altman-Z 5.54
F-Score3
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)253.71%
Cap/Depr(5y)307.54%
Cap/Sales(3y)5.17%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-421.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26%
EPS Next Y113.33%
EPS Next 2Y61.1%
EPS Next 3Y36.59%
EPS Next 5Y34.48%
Revenue 1Y (TTM)-23.72%
Revenue growth 3Y-5.57%
Revenue growth 5Y7.93%
Sales Q2Q%18.08%
Revenue Next Year22%
Revenue Next 2Y14.87%
Revenue Next 3Y12.7%
Revenue Next 5Y13.36%
EBIT growth 1Y-264.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year153.88%
EBIT Next 3Y42.24%
EBIT Next 5Y27.01%
FCF growth 1Y-422.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-317.68%
OCF growth 3YN/A
OCF growth 5YN/A

STAAR SURGICAL CO / STAA Fundamental Analysis FAQ

What is the fundamental rating for STAA stock?

ChartMill assigns a fundamental rating of 4 / 10 to STAA.


Can you provide the valuation status for STAAR SURGICAL CO?

ChartMill assigns a valuation rating of 2 / 10 to STAAR SURGICAL CO (STAA). This can be considered as Overvalued.


What is the profitability of STAA stock?

STAAR SURGICAL CO (STAA) has a profitability rating of 2 / 10.


How financially healthy is STAAR SURGICAL CO?

The financial health rating of STAAR SURGICAL CO (STAA) is 8 / 10.